CD101: A versatile molecule associated with immunoregulatory and antimicrobial functions.

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• CD101 is an immunoglobulin-like glycoprotein with a unique EWI motif.
• Allelic variations in the Cd101 gene affect CD101 expression and function in myeloid and T cells.
• CD101 acts as a maturation marker for neutrophils and a differentiation marker for dendritic cells (DCs), eosinophils, and T cell subsets.

Purpose of the Study:

• To review current information on the immune-modulatory and anti-microbial functions of CD101.
• To discuss the potential role of CD101 as a biomarker for inflammatory and infectious diseases.
• To explore CD101's predictive value in cancer immunotherapy outcomes.

Main Methods:

• Literature review of existing studies on CD101.
• Analysis of CD101 expression patterns in various immune cells and disease states.
• Correlation of CD101 function with cellular phenotypes and disease outcomes.

Main Results:

• CD101 expression is cell-specific and correlates with diverse functional responses.
• Increased CD101 on eosinophils and T cells is linked to chronic disorders.
• Reduced CD101 on myeloid cells is observed during acute inflammation and infections.
• CD101 expression on myeloid cells and regulatory T cells enhances protection against enterocolitis and type 1 diabetes.
• CD101-expressing neutrophils show improved bacterial infection control.
• CD101 expression on eosinophils is associated with heightened inflammatory responses.

Conclusions:

• CD101 simultaneously restricts microbial infections and regulates immune-mediated tissue damage.
• CD101's diverse functions and regulatory mechanisms require further investigation.
• CD101 holds potential as a biomarker for inflammatory/infectious diseases and a predictor for cancer immunotherapy success.